Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BChE-IN-8 (compound 20) is an orally active BChE (butyrylcholinesterase) inhibitor that crosses the blood-brain barrier and acts on eqBChE (IC50: 0.15 nM), hBChE (IC50: 45.2 nM). BChE-IN-8 can be used in the study of Alzheimer's disease (AD), where it can exert neuroprotective and cognitive improvement effects through a variety of regulatory mechanisms, including the cholinergic system, Aβ aggregation and neuropeptide levels.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BChE-IN-8 (compound 20) is an orally active BChE (butyrylcholinesterase) inhibitor that crosses the blood-brain barrier and acts on eqBChE (IC50: 0.15 nM), hBChE (IC50: 45.2 nM). BChE-IN-8 can be used in the study of Alzheimer's disease (AD), where it can exert neuroprotective and cognitive improvement effects through a variety of regulatory mechanisms, including the cholinergic system, Aβ aggregation and neuropeptide levels. |
Molecular Weight | 438.24 |
Formula | C18H12BrN7O2 |
CAS No. | 2653349-78-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BChE-IN-8 2653349-78-9 inhibitor inhibit